BackArcturus Therapeutics Holdings Overview
Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics Holdings Target Price

See Arcturus Therapeutics Holdings's analyst price targets ($31) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$10.87

Average Target Price

$30.50180.6% upside

2 analysts in the last 4 months

High: $41 | Low: $20

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-24BTIGThomas Shrader$2084% upsideOpen
2026-09-02Roth Capital$41277.2% upsideOpen
2026-03-04Piper SandlerYasmeen Rahimi$25130% upsideOpen
2026-01-22Roth Capital$2084% upsideOpen
2025-08-22Leerink PartnersLili Nsongo$54396.8% upsideOpen
2025-05-28ScotiabankGreg Harrison$32194.4% upsideOpen
2025-03-10BTIGThomas Shrader$48341.6% upsideOpen
2024-11-11Canaccord GenuityWhitney Ijem$10.582.7% downsideOpen
2024-08-06Canaccord GenuityWhitney Ijem$10.35.2% downsideOpen
2024-07-02H.C. WainwrightEd Arce$8.5821.1% downsideOpen
2024-05-31Piper SandlerYasmeen Rahimi$20.0284.2% upsideOpen
2024-05-10Canaccord GenuityWhitney Ijem$12.313.2% upsideOpen
2024-03-19LaidlawYale Jen$11.34% upsideOpen
2022-11-02BarclaysGena Wang$25130% upsideOpen
2022-05-11Goldman Sachs$1428.8% upsideOpen
2021-11-09Goldman SachsMadhu Kumar$30176% upsideOpen

Arcturus Therapeutics Holdings (ARCT) FAQ

As of the most recent data, ARCT shows a target price of $31. Scroll down for historical charts and peer comparison views.

If Arcturus Therapeutics Holdings moved to the average analyst target of $31, shares would be roughly 180.6% higher than $10.87. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Arcturus Therapeutics Holdings's earnings trajectory.

Besides this target price page, Stockcircle has Arcturus Therapeutics Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $31) with ownership activity and broader fundamentals.

Arcturus Therapeutics Holdings's target price is $31; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.